Entera Bio Ltd. financial data

Symbol
ENTXW, ENTX on Nasdaq
Location
Jerusalem
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1070% % 30%
Debt-to-equity 14% % -16%
Return On Equity -72% % 33%
Return On Assets -63% % 31%
Operating Margin -8729% % 6.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45,857,242 shares 25%
Common Stock, Shares, Outstanding 45,664,506 shares 25%
Entity Public Float $58,800,000 USD 184%
Common Stock, Value, Issued $1,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 47,089,814 shares 25%
Weighted Average Number of Shares Outstanding, Diluted 47,089,814 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $124,000 USD 25%
Cost of Revenue $124,000 USD 38%
Research and Development Expense $5,487,000 USD 28%
General and Administrative Expense $5,337,000 USD 8.2%
Operating Income (Loss) $10,824,000 USD -18%
Nonoperating Income (Expense) $57,000 USD 73%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,021,000 USD -29%
Income Tax Expense (Benefit) $0 USD -100%
Net Income (Loss) Attributable to Parent $10,781,000 USD -17%
Earnings Per Share, Basic 0 USD/shares -3.8%
Earnings Per Share, Diluted 0 USD/shares -3.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,574,000 USD 24%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD -100%
Other Assets, Current $262,000 USD 194%
Assets, Current $17,007,000 USD 132%
Deferred Income Tax Assets, Net $0 USD -100%
Property, Plant and Equipment, Net $114,000 USD 75%
Operating Lease, Right-of-Use Asset $194,000 USD -39%
Assets $17,407,000 USD 125%
Accounts Payable, Current $216,000 USD 17%
Liabilities, Current $1,571,000 USD 41%
Operating Lease, Liability, Noncurrent $41,000 USD -72%
Liabilities $2,173,000 USD 69%
Accumulated Other Comprehensive Income (Loss), Net of Tax $41,000 USD 0%
Retained Earnings (Accumulated Deficit) $122,350,000 USD -9.7%
Stockholders' Equity Attributable to Parent $15,234,000 USD 136%
Liabilities and Equity $17,407,000 USD 125%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,404,000 USD 25%
Net Cash Provided by (Used in) Financing Activities $13,337,000 USD 44357%
Net Cash Provided by (Used in) Investing Activities $8,000 USD
Common Stock, Shares Authorized 140,010,000 shares 0%
Common Stock, Shares, Issued 45,664,506 shares 25%
Common Stock, Par or Stated Value Per Share 0 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $11,925,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16,688,000 USD 139%
Deferred Tax Assets, Valuation Allowance $20,873,000 USD 7.2%
Deferred Tax Assets, Gross $20,873,000 USD 7.1%
Operating Lease, Liability $272,000 USD -30%
Depreciation $8,000 USD -38%
Payments to Acquire Property, Plant, and Equipment $8,000 USD
Lessee, Operating Lease, Liability, to be Paid $301,000 USD -34%
Operating Lease, Liability, Current $170,000 USD 4.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $101,000 USD -45%
Lessee, Operating Lease, Liability, to be Paid, Year One $198,000 USD 7.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29,000 USD -55%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,000 USD -98%
Deferred Tax Assets, Operating Loss Carryforwards $19,208,000 USD 10%
Deferred Tax Assets, Net of Valuation Allowance $0 USD -100%